Literature DB >> 15064490

Chromogenic in situ hybridization in tumor pathology.

Jorma Isola1, Minna Tanner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15064490     DOI： 10.1385/1-59259-760-2:133

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  6 in total

1.  Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.

Authors:  Birgitta Schlüter; Roswitha Gerhards; Dirk Strumberg; Rudolf Voigtmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

2.  Determination of HER-2 status on FNAC material from breast carcinomas using in situ hybridization with dual chromogen visualization with silver enhancement (dual SISH).

Authors:  Elsa Beraki; Torill Sauer
Journal:  Cytojournal       Date:  2010-10-11       Impact factor: 2.091

3.  ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity.

Authors:  Mohamed Oueslati; Ilhem Bittaieb; Nadia Sassi; Awatef Ben Jemaa; Amor Gamoudi; Khaled Rahal; Ridha Oueslati
Journal:  Oncol Lett       Date:  2017-06-06       Impact factor: 2.967

4.  The Significance of MET Expression and Strategies of Targeting MET Treatment in Advanced Gastric Cancer.

Authors:  Haiyan Liao; Tiantian Tian; Yuling Sheng; Zhi Peng; Zhongwu Li; Jingyuan Wang; Yanyan Li; Cheng Zhang; Jing Gao
Journal:  Front Oncol       Date:  2021-09-07       Impact factor: 6.244

5.  Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.

Authors:  Mario Scartozzi; Italo Bearzi; Alessandra Mandolesi; Chiara Pierantoni; Fotios Loupakis; Alberto Zaniboni; Francesca Negri; Antonello Quadri; Fausto Zorzi; Eva Galizia; Rossana Berardi; Tommasina Biscotti; Roberto Labianca; Gianluca Masi; Alfredo Falcone; Stefano Cascinu
Journal:  BMC Cancer       Date:  2009-08-27       Impact factor: 4.430

6.  FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.

Authors:  Somaia Elbauomy Elsheikh; Andrew R Green; Maryou B K Lambros; Nicholas C Turner; Matthew J Grainge; Des Powe; Ian O Ellis; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.